{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:35:19Z","timestamp":1792697719054,"version":"4.5.0"},"reference-count":100,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T00:00:00Z","timestamp":1496793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0178611","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T17:31:15Z","timestamp":1496856675000},"page":"e0178611","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":59,"title":["Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies"],"prefix":"10.1371","volume":"12","author":[{"given":"Mohamed Hosny","family":"Osman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman","family":"Farrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Samy","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Hasanine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azza","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,6,7]]},"reference":[{"key":"ref1","unstructured":"World Health Organization (WHO) Cancer Fact sheet N\u00b0297 [Internet]."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.27711","article-title":"Global estimates of cancer prevalence for 27 sites in the adult population in 2008","volume":"132","author":"F Bray","year":"2013","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"J Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ejca.2007.12.015","article-title":"Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s","volume":"44","author":"HE Karim-Kos","year":"2008","journal-title":"Eur J Cancer"},{"key":"ref5","first-page":"3","article-title":"Global battle against cancer won\u2019t be won with treatment alone\u2014effective prevention measures urgently needed to prevent cancer crisis","volume":"22","author":"S America","year":"2014","journal-title":"Cent Eur J Public Health"},{"key":"ref6","first-page":"29","article-title":"Is digoxin a breast cancer risk factor? Acute cardiac care","author":"S Masood","year":"2015"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/2159-8274.CD-10-0020","article-title":"A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment","volume":"1","author":"EA Platz","year":"2011","journal-title":"CANCER Discov"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0736-4679(86)90048-X","article-title":"Therapeutic and toxic effects of digitalis: William Withering, 1785","volume":"4","author":"HA Bessen","year":"1986","journal-title":"J Emerg Med"},{"key":"ref9","article-title":"Harrison\u2019s Principles of Internal Medicine","author":"FA Harrison TR","year":"1998"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10637-013-9984-1","article-title":"Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials","volume":"31","author":"M Slingerland","year":"2013","journal-title":"Invest New Drugs"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrm1150","article-title":"Regulation of cell death: the calcium-apoptosis link","volume":"4","author":"S Orrenius","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1124\/mol.104.007302","article-title":"Digitalis-induced signaling by Na+\/K+-ATPase in human breast cancer cells","volume":"67","author":"P Kometiani","year":"2005","journal-title":"Mol Pharmacol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"TT Ashburn","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"19579","DOI":"10.1073\/pnas.0809763105","article-title":"Digoxin and other cardiac glycosides inhibit HIF-1alpha synthesis and block tumor growth","volume":"105","author":"H Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1158\/1078-0432.CCR-11-1389","article-title":"Molecular Pathways: Digoxin Use and Estrogen-Sensitive Cancers-Risks and Possible Therapeutic Implications","volume":"18","author":"RJ Biggar","year":"2012","journal-title":"Clin CANCER Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1471-2407-1-11","article-title":"Digitoxin medication and cancer; case control and internal dose-response studies","volume":"1","author":"J Haux","year":"2001","journal-title":"BMC Cancer. England"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ. England"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"DF Stroup","year":"2000","journal-title":"JAMA"},{"key":"ref19","unstructured":"Wells GA, Shea B, O\u2019Connell D, Peterson J, Welch V et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\" xlink:type=\"simple\">http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp<\/ext-link>. 2012."},{"key":"ref20","article-title":"Calcium channel blockers and risk of breast cancer: A meta-analysis of 17 observational studies","volume":"9","author":"W Li","year":"2014","journal-title":"PLoS One"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1158\/1055-9965.EPI-15-0452","article-title":"Aspirin use and risk of breast cancer: Systematic review and meta-analysis of observational studies","volume":"24","author":"S Zhong","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/oxfordjournals.aje.a114083","article-title":"Another shortcut method for calculating the confidence interval of a Poisson variable (or of a standardized mortality ratio)","author":"HK Ury","year":"1985","journal-title":"American journal of epidemiology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JPT Higgins","year":"2002","journal-title":"Stat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"key":"ref26","unstructured":"Borenstein, M., L. Hedges, J. Higgins and HR. Comprehensive meta-analysis version 2.2.064. Comprehensive meta-analysis software. 2005. p. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.meta\u2013analysis.com\" xlink:type=\"simple\">http:\/\/www.meta\u2013analysis.com<\/ext-link>."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/ijc.2910180603","article-title":"Breast cancer and use of rauwolfia and other antihypertensive agents in hypertensive patients: a nationwide case-control study in Finland","volume":"18","author":"A Aromaa","year":"1976","journal-title":"Int J cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/ijc.2910450415","article-title":"Risk factors for male breast cancer: a Franco-Swiss case-control study","volume":"45","author":"MH Lenfant-Pejovic","year":"1990","journal-title":"Int J cancer"},{"key":"ref29","first-page":"S5510","article-title":"PRIOR MEDICATION USE AND HEALTH HISTORY AS RISK-FACTORS FOR NON-HODGKINS-LYMPHOMA\u2014PRELIMINARY-RESULTS FROM A CASE-CONTROL STUDY IN LOS-ANGELES-COUNTY","volume":"52","author":"L BERNSTEIN","year":"1992","journal-title":"CANCER Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1099-1557(199803\/04)7:2<99::AID-PDS320>3.0.CO;2-0","article-title":"Drugs and colon cancer","volume":"7","author":"GD Friedman","year":"1998","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/028418601750288181","article-title":"Risk factors for male breast cancer\u2014A case-control study from Scandinavia","volume":"40","author":"M Ewertz","year":"2001","journal-title":"Acta Oncol (Madr)"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1186\/bcr2205","article-title":"Digoxin treatment is associated with an increased incidence of breast cancer: a population-based case-control study","volume":"10","author":"TP Ahern","year":"2008","journal-title":"BREAST CANCER Res"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/pds.3717","article-title":"Digoxin use and the risk for colorectal cancer","volume":"23","author":"B Boursi","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10549-014-3058-8","article-title":"Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia","volume":"146","author":"S Couraud","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"ref35","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-14-573","article-title":"Cardiac glycosides use and the risk of lung cancer: a nested case-control study","volume":"14","author":"S Couraud","year":"2014","journal-title":"BMC Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/pros.22733","article-title":"Is Digoxin Use for Cardiovascular Disease Associated With Risk of Prostate Cancer?","volume":"74","author":"JL Wright","year":"2014","journal-title":"Prostate"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/ijc.29470","article-title":"Sotalol, but not digoxin is associated with decreased prostate cancer risk: A population-based case-control study","volume":"137","author":"KJ Kaapu","year":"2015","journal-title":"Int J CANCER"},{"key":"ref38","article-title":"Ion channel blockers and glioblastoma risk and outcome: a nested case-control and retrospective cohort studies","author":"B Boursi","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11060-015-2036-2","article-title":"Use of cardiac glycosides and risk of glioma","volume":"127","author":"C Seliger","year":"2016","journal-title":"J Neurooncol"},{"key":"ref40","first-page":"1326","article-title":"A case-control study of male breast cancer","volume":"48","author":"JT Casagrande","year":"1988","journal-title":"Cancer Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/oxfordjournals.aje.a113416","article-title":"Nonestrogenic drugs and breast cancer","volume":"116","author":"DA Danielson","year":"1982","journal-title":"Am J Epidemiol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(84)90915-2","article-title":"DIGITALIS AND BREAST-CANCER","volume":"2","author":"GD FRIEDMAN","year":"1984","journal-title":"Lancet"},{"key":"ref43","first-page":"5736","article-title":"Screening Prescription Drugs for Possible Carcinogenicity: Eleven to Fifteen Years of Follow-up","volume":"49","author":"J V Selby","year":"1989","journal-title":"Cancer Res"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1200\/JCO.2010.32.8146","article-title":"Digoxin Use and the Risk of Breast Cancer in Women","volume":"29","author":"RJ Biggar","year":"2011","journal-title":"J Clin Oncol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/2159-8274.CD-10-0020","article-title":"A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer Treatment","volume":"1","author":"EA Platz","year":"2011","journal-title":"CANCER Discov"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ijc.26424","article-title":"Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix","volume":"131","author":"RJ Biggar","year":"2012","journal-title":"Int J CANCER"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e2013003","DOI":"10.4178\/epih\/e2013003","article-title":"Cohort study of risk factors for breast cancer in post menopausal women","volume":"35","author":"AJ Hartz","year":"2013","journal-title":"Epidemiol Health"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10549-014-2886-x","article-title":"Digoxin use and risk of invasive breast cancer: evidence from the Nurses\u2019 Health Study and meta-analysis","volume":"144","author":"TP Ahern","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bju.12287","article-title":"A cohort study of digoxin exposure and mortality in men with prostate cancer","volume":"113","author":"EM Flahavan","year":"2014","journal-title":"BJU Int"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s10549-015-3417-0","article-title":"Digoxin use after diagnosis of breast cancer and survival: a population-based cohort study","volume":"151","author":"RA Karasneh","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/1055-9965.EPI-15-0694","article-title":"Digoxin Use After Diagnosis of Colorectal Cancer and Survival: A Population-Based Cohort Study","volume":"24","author":"RA Karasneh","year":"2015","journal-title":"CANCER Epidemiol BIOMARKERS {&} Prev"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10552-015-0693-2","article-title":"Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial","volume":"27","author":"KJ Kaapu","year":"2016","journal-title":"CANCER CAUSES Control"},{"key":"ref53","article-title":"Digoxin use after diagnosis of prostate cancer and survival: a population-based cohort study","author":"RA Karasneh","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2015.12.003","article-title":"Digoxin therapy is not associated with improved survival in epithelial ovarian cancer: A SEER-Medicare database analysis","volume":"140","author":"TJ Vogel","year":"2016","journal-title":"Gynecol Oncol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbcan.2007.06.002","article-title":"Cardiotonic steroids on the road to anti-cancer therapy","volume":"1776","author":"T Mijatovic","year":"2007","journal-title":"Biochim Biophys ACTA-REVIEWS CANCER"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jcem-46-2-338","article-title":"Interaction of digitalis and spironolactone with human sex steroid receptors","volume":"46","author":"SM Rifka","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/endo-99-4-1091","article-title":"Mechanism of interaction of digitalis with estradiol binding sites in rat uteri","volume":"99","author":"SM Rifka","year":"1976","journal-title":"Endocrinology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1210\/endo-99-4-1091","article-title":"Mechanism of interaction of digitalis with estradiol binding sites in rat uteri","volume":"99","author":"SM Rifka","year":"1976","journal-title":"Endocrinology"},{"key":"ref59","first-page":"338","article-title":"Reverse T3 in screening for neonatal hypothyroidism, Lancet 2: 39, 1976. Interaction of Digitalis and Spironolactone with Human Sex Steroid Receptors","volume":"46","author":"A Burger","year":"1978","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsbmb.2006.09.004","article-title":"The role of estrogen in the initiation of breast cancer","volume":"102","author":"J Russo","year":"2006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1248\/bpb.29.1493","article-title":"Inhibition of DNA topoisomerases I and II, and growth inhibition of breast cancer MCF-7 cells by ouabain, digoxin and proscillaridin A","volume":"29","author":"K Bielawski","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1007\/BF02980262","article-title":"Apoptosis-mediated cytotoxicity of ouabain, digoxin and proscillaridin A in the estrogen independent MDA-MB-231 breast cancer cells","volume":"30","author":"K Winnicka","year":"2007","journal-title":"Arch Pharm Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4103\/1477-3163.72578","article-title":"Digitoxin activates EGR1 and synergizes with paclitaxel on human breast cancer cells","volume":"9","author":"LS Einbond","year":"2010","journal-title":"J Carcinog. India"},{"key":"ref64","article-title":"Basic and Clinical Pharmacology","author":"BG Katzung","year":"2001"},{"key":"ref65","first-page":"1399","article-title":"Suppression of breast cancer cells by cardiac glycosides","volume":"19","author":"I Kimijima","year":"1992","journal-title":"Gan To Kagaku Ryoho"},{"key":"ref66","first-page":"68","article-title":"NIH Public Access","volume":"2011","author":"T Study","year":"2011","journal-title":"Cancer"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1634\/theoncologist.5-1-36","article-title":"Management of Advanced Prostate Cancer","volume":"5","author":"G Auclerc","year":"2000","journal-title":"Oncologist"},{"key":"ref68","first-page":"1190","article-title":"Estradiol inhibits growth of hormone-nonresponsive PC3 human prostate cancer cells","volume":"54","author":"G Carruba","year":"1994","journal-title":"Cancer Res"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/jnci\/88.13.908","article-title":"Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells","volume":"88","author":"CN Robertson","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"ref70","first-page":"1003","article-title":"Inhibition of androgen-independent growth of prostate cancer xenografts by 17beta-estradiol","volume":"8","author":"E Corey","year":"2002","journal-title":"Clin Cancer Res"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1080\/00365590801943274","article-title":"Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer: part 2. Final evaluation of the Scandinavian Prostatic Cancer Group (SPCG) Study No. 5","volume":"42","author":"PO Hedlund","year":"2008","journal-title":"Scand J Urol Nephrol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0022-5347(05)65724-2","article-title":"Inhibitory effects of digitalis on the proliferation of androgen dependent and independent prostate cancer cells","volume":"166","author":"JY Yeh","year":"2001","journal-title":"J Urol"},{"key":"ref73","first-page":"3807","article-title":"Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells","volume":"60","author":"DJ McConkey","year":"2000","journal-title":"CANCER Res"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1016\/j.juro.2010.06.093","article-title":"Cardiac Glycosides Decrease Prostate Specific Antigen Expression by Down-Regulation of Prostate Derived Ets Factor","volume":"184","author":"H-H Juang","year":"2010","journal-title":"J Urol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"6688","DOI":"10.1158\/0008-5472.CAN-07-6833","article-title":"Inhibition of the sodium\/potassium ATPase impairs N-glycan expression and function","volume":"68","author":"RB Zavareh","year":"2008","journal-title":"CANCER Res"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"29302","DOI":"10.1074\/jbc.M403664200","article-title":"Involvement of Cdk5\/p25 in digoxin-triggered prostate cancer cell apoptosis","volume":"279","author":"H Lin","year":"2004","journal-title":"J Biol Chem"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-5793(04)00292-3","article-title":"Up-regulation of Na+K+-ATPase alpha 3-isoform and down-regulation of the alpha 1-isoform in human colorectal cancer","volume":"563","author":"H Sakai","year":"2004","journal-title":"FEBS Lett"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1200\/JCO.2012.42.7732","article-title":"Estrogen plus progestin and colorectal cancer incidence and mortality","volume":"30","author":"MS Simon","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.maturitas.2009.11.027","article-title":"Menopausal hormone therapy and risk of lung cancer-Systematic review and meta-analysis","volume":"65","author":"CM Greiser","year":"2010","journal-title":"Maturitas"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1006\/bbrc.2001.5158","article-title":"Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers","volume":"285","author":"Y Omoto","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"ref81","first-page":"337","article-title":"Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis","volume":"28","author":"MJ Jarzynka","year":"2006","journal-title":"Int J Oncol"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1677\/ERC-08-0002","article-title":"Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma","volume":"15","author":"Z Hammoud","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJM195302192480802","article-title":"Gynecomastia during digitalis therapy; report of eight additional cases with liver-function studies","volume":"248","author":"EB LEWINN","year":"1953","journal-title":"N Engl J Med"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1023\/B:CACO.0000036154.18162.43","article-title":"Alcohol drinking may increase risk of breast cancer in men: a European population-based case-control study","volume":"15","author":"P Guenel","year":"2004","journal-title":"Cancer Causes Control"},{"key":"ref85","first-page":"4812","article-title":"Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer","volume":"42","author":"RJ Pegoraro","year":"1982","journal-title":"Cancer Res"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/1055-9965.20.14.1","article-title":"Epidemiology of male breast cancer","volume":"14","author":"JR Weiss","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00000478-200001000-00009","article-title":"Short-term and long-term histologic effects of castration and estrogen treatment on breast tissue of 14 male-to-female transsexuals in comparison with two chemically castrated men","volume":"24","author":"RC Kanhai","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11060-014-1427-0","article-title":"Reproductive factors and risk of primary brain tumors in women","volume":"118","author":"GM Anic","year":"2014","journal-title":"J Neurooncol"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1158\/1535-7163.MCT-11-0960","article-title":"Therapeutic significance of estrogen receptor beta agonists in gliomas","volume":"11","author":"GR Sareddy","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0039-128X(00)00122-7","article-title":"Progestins and menopause: epidemiological studies of risks of endometrial and breast cancer","volume":"65","author":"MC Pike","year":"2000","journal-title":"Steroids"},{"key":"ref91","first-page":"1051","article-title":"Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the \u201cMALOVA\u201d ovarian cancer study","volume":"18","author":"EVS Hogdall","year":"2007","journal-title":"Oncol Rep. Greece"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/1097-0142(19900201)65:3<486::AID-CNCR2820650319>3.0.CO;2-C","article-title":"Estrogen and progesterone receptors in ovarian cancer","volume":"65","author":"M Harding","year":"1990","journal-title":"Cancer"},{"key":"ref93","first-page":"648","article-title":"Estrogen and progesterone receptors in normal cervix and primary cervical carcinoma","volume":"107","author":"K Shen","year":"1994","journal-title":"Chin Med J (Engl)"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1158\/0008-5472.CAN-08-2051","article-title":"Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer","volume":"68","author":"S-H Chung","year":"2008","journal-title":"Cancer Res"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1073\/pnas.0409883102","article-title":"Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model","volume":"102","author":"T Brake","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref96","doi-asserted-by":"crossref","first-page":"19467","DOI":"10.1073\/pnas.0911436106","article-title":"Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists","volume":"106","author":"S-H Chung","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref97","first-page":"1466","article-title":"Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia","volume":"11","author":"JR Cerhan","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref98","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/aje\/kwn119","article-title":"Non-Hodgkin lymphoma in women: reproductive factors and exogenous hormone use","volume":"168","author":"JS Lee","year":"2008","journal-title":"Am J Epidemiol"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3109\/10428194.2012.722216","article-title":"Postmenopausal unopposed estrogen and estrogen plus progestin use and risk of non-Hodgkin lymphoma in the American Cancer Society Cancer Prevention Study-II Cohort","volume":"54","author":"LR Teras","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s10637-006-7772-x","article-title":"Phase 1 trial of Anvirzel in patients with refractory solid tumors","volume":"24","author":"T Mekhail","year":"2006","journal-title":"Invest New Drugs"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0178611","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T07:31:15Z","timestamp":1659079875000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0178611"}},"subtitle":[],"editor":[{"given":"Luis Eduardo M.","family":"Quintas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,6,7]]},"references-count":100,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,6,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0178611","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,7]]}}}